1. Selling put options on Intel and CRISPR Therapeutics offers high returns with moderate risk; 2. Intel's $22 strike June 20th puts provide a 19.07% annualized yield; 3. CRISPR's $30 strike July 18th puts offer a 13.51% annualized yield.